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Cet article analyse l’histoire du conseil génétique et du diagnos-
tic prénatal en France. Il s’agit plus spéciﬁquement de revenir sur
le processus de molécularisation de l’hérédité et des maladies qui
est intervenu à partir de la Seconde Guerre mondiale et sur ses
conséquences au niveau des pratiques médicales. L’article est
organisé en trois sections. La première discute l’héritage de
l’eugénisme et la spéciﬁcité de la conﬁguration dominant en
France laquelle articulait médecine sociale, natalisme et hérédité
pathologique. La seconde section revient sur le développement
de la recherche médicale et sur les nouvelles déﬁnitions, molécu-
laires, de l’hérédité pathologique qui sont apparues après 1945et
ont contribué à l’apparition du conseil génétique. La troisième
section présente quelques hypothèses sur la transformation du
conseil génétique en pratique de masse et sur ses origines tech-
nologiques. Pour donner à ce survol une dimension plus concrète,
l’article utilise comme marqueur les changements d’usage des
arbres généalogiques.
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A Londonmedical student coming to Paris in the late 1930s to study psychiatry ormental disorders
would have faced an intellectual landscape quite different from the one he had left at home. At the
time, the British medical and social arenas resonated with highly controversial debates about the
relationship between genetics, heredity, mental retardation, and madness in general. These debates
were directly linked to institutional and public policy questions regarding the future of asylums and
poorhouses, the organization of psychiatry, andputative legislation authorizing voluntary sterilization
(Kevles, 1985; Ricard, 2002). Once in Paris, our medical traveler would have noticed not only the
absence of health-policy debates of this kind, but also how scarcely French practitioners referred to
genetics as well as how frequently they used concepts such as familial transmission, constitution, or
“terrain” (Carol, 1995; Schneider, 1990).
Twenty years later, by the late 1950s, a similar experience of barely compatible social and medical
worlds would no longer be possible. By that time, French specialists in hereditary diseases working in
Paris hospitals and the elite medical schools were using the same genetic tools that were advocated
by their British colleagues: concepts including inborn errors of metabolism, recessive (respectively
dominant) hereditary characters, Mendel laws of hereditary transmission, and measurement devices
such as pedigree charts and biochemical tests (Gaudillière, 2002).
The aim of this paper is to explore this transformation through the genealogy of genetic counseling.
The “geneticization” of pathological heredity in the 20th century has been addressed in various ways
within the recent historiography of biomedicine. The perspective adopted here is to reﬂect upon the
ways in which medical practices were impacted by the molecularization of diseases and heredity that
took place after World War II, and more speciﬁcally, how this changed the management of pregnancy
and the care of newborns. The paper is organized into three sections. The ﬁrst discusses the legacy
of eugenics and the speciﬁcity of the sociomedical conﬁguration prevailing in France, which linked
social medicine, natalism, and the deﬁnition of pathological inheritance. The second section describes
how the development of biomedical research after 1945 resulted in a new—molecular—deﬁnition of
hereditary pathologywith the emergence of genetic counseling as a correlate. The third section ismore
speculative and presents a few hypotheses regarding the mass development of genetic diagnosis in
the 1970s and 1980s, and its technological roots. To make this overview more concrete and speciﬁc,
the paper follows the uses of family trees as markers of this transformation.
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Legacy of French eugenics
Historical studies of eugenics have often insisted on national differences in the ways of problema-
tizing the question of pathological inheritance and its social bearings, and on the policies and targets of
intervention based on this problematization.1 In contrast to the situation prevailing in Britain, eugen-
ics in France was a medical issue (Carol, 1995). One marker of this status is the fact that physicians,
especially those specializing in reproductive medicine, i.e. obstetricians, gynecologists, and pediatri-
cians, were very active in the local Eugenics Society (Société franc¸aise d’eugénique). More importantly,
the problems eugenics was to tackle were included in a broader hygiene nebula. Accordingly, the doc-
tors participating in the Eugenics Society were also engaged in societies ﬁghting against tuberculosis,
venereal diseases, or population decline, leaving madness aside. They often considered, taking tuber-
culosis as a paradigmatic example, that hereditary transmission of diseases was above all a question
of constitution and predisposition, the inﬂuence of which on an individual’s life could be controlled
through changes in the familial and social environment. The concept of “hérédo-contagion” waswidely
used in articles and pamphlets, while “sélection” remained peripheral when present, which was rare.
One major difference with the British eugenics complex was however the stamp, on the French move-
ment, of a natalist perspective and natalist policies. After World War I, ﬁghting depopulation and the
declining birth rate became adominantmotto in social policies and socialmedicine, leading to a strong
medical support of the 1920 law banning contraception and abortion. In contrast to the British move-
ment in favor of birth control, the goal of the moment was to induce mothers to have more babies
rather than to organize the selection of the lives to come by prohibiting the reproduction of the less
ﬁt. Quantity, rather than quality of the population was what mattered.
This social and cultural context had two important cognitive consequences. The ﬁrst was the med-
ical marginality of Mendelian genetics. In 1919, a famous pediatrician and ofﬁcial of the Eugenics
Society, Eugène Apert, published L’hérédité morbide, a textbook for medical students (Apert, 1919).
Apert was among the ﬁrst clinicians in the country to include pedigrees exemplifying the existence
of human-disease transmission patterns ﬁtting a Mendelian distribution of characters, for instance
in the case of hemophilia. This reference to genetics even provided Apert with a special category,
that of familial diseases. He considered, however, that “identical transmission of a disease to the next
generation, which may be called inheritance of the like, [was] rare.” Constitution, external inﬂuence,
and degeneration remained the prevailing traits of pathological heredity: “Bear in mind that familial
diseases constitute just a small corner within a vast ﬁeld. If, for instance, the father is a drunk, he
will produce a son differing from the normal type in his lineage. Within this family, there will be a
tendency to degenerate, since the sperm of the father, or better said, the cells from which it derives,
has been the target of obnoxious effects originating in the bad condition of the paternal organism.”
Rather than Mendelian charts associated with the computation of a transmission ratio, the pedigrees
used in this medical culture were eugenic family trees displaying entire social groups instead of just
nuclear families. These pedigrees combined biological and social traits, documenting the many facets
of pathological lives—up to and including madness, pulmonary infections, and work accidents—thus
illustrating degeneration through successive generations, as well as the deterioration of health.2
The second—and more enduring—consequence of the medical framing of eugenics in France was
the development of investigations, which favored an all-encompassing understanding of generation
and the integration of heredity as only one aspect within a global approach to disease transmission in
families (Gaudillière and Löwy, 2000). This can be illustrated with the work of another Parisian pedi-
atrician, Raymond Turpin, who in the 1930s was head of a clinical service at the Saint-Louis hospital.
“Mongolism” was among the most important research topics in the palette of articles produced by
Turpin’s service. Mongolism was important for the medical understanding of constitutional and con-
genetical disorders for three reasons: it was a relatively commondisease; its diagnosiswas considered
easy; it started in the newborn. At the time, the diagnosis relied on purely clinical and morphological
criteria. The “signs” of the “Mongolian series” included epicanthus, hypotonia, abnormal palm lines,
1 In addition to the works cited above, see for the German case (Weindling, 1989 and Proctor, 1988).
2 For a more thorough discussion of eugenic pedigrees (Mazumdar, 1992).
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and furrowed tongue. Therewas no agreement on a precise etiology (Benda, 1949, 1960). Hereditywas
usually ruled out for lack of family clustering in favor of unspeciﬁed maternal constitutional factors
that were considered to prevent a normal development of the embryo.
Turpin’s research on “mongol” patients objectiﬁed these inﬂuences, but it also helped transform
them into more speciﬁc genetic predispositions including Mendelian factors (Gaudillière, 2000a).
Organizing family surveys of a few dozen Mongol patients, Turpin and his colleagues ﬁrst sought to
document the factors thatmight affect the relationship betweenmothers, fetuses, andnewborns. They
looked, for instance, at growth abnormalities, birth order, the incidence of syphilis, or parental age.
They came up with what has been remembered of this work, namely the importance of the mother’s
age, providing evidence of a statistical link between the mothers’ age and an increasing incidence of
the disease. In parallel to maternal inﬂuences, Turpin and Armand Caratzali looked for early signs of
the disease among the parents and kin of the affected children. The most obvious candidate for the
role of predisposing factor, not to say causal factor, was the furrowed tongue frequently displayed by
the parents. Moreover, pedigree studies revealed that this anomaly was transmitted as a dominant
Mendelian factor. The familial imprint was however twofold: physiological and genetic. Both con-
tributed to mutations in the fetus, a phenomenon Turpin tentatively considered to be the direct cause
of the disease. Thus, not only did his model of pathological inheritance resonate with the dominant
culture of transmission, it also echoed broad medical concerns with late pregnancy, delays in child
bearing, and the declining birth rate.
Early biomedicalization: chromosomes, pedigrees, and genetic counseling
The ﬁrst postwar decade was a time of reconstruction in all the sectors of the country’s life. The
health-care system was signiﬁcantly changed with the institution of a national health-insurance sys-
tem providing payment of medical care for all workers and their relatives. State intervention was
increasingly seen as a normal mechanism to foster economic growth, as well as social reform when it
was deemed necessary. As part of the trend toward the planiﬁcation and institutionalization of state
policies, science became a target of national public policy with the establishment (or the reinforce-
ment) of agencies suchas theCentrenational de la recherche scientiﬁqueor the Institut national d’hygiène,
which not only supported research in a few universities but more importantly, set up their own lab-
oratories (Picard, 1992). At the crossroads of these two tendencies, science was increasingly viewed
as a critical asset on the path toward medical progress. Medical research was however not necessar-
ily synonymous of clinical, human, and hospital-based investigations. Within a general framework
that favored national agencies and their laboratories, emphasis was placed on the need for “basic”
knowledge. Scientiﬁc reconstruction privileged biomedicine and, to borrow the term coined by the
virus specialists working at the Pasteur Institute, the “demedicalization” of domains once consid-
ered as disciplines subordinated to clinical knowledge, such as biochemistry, bacteriology, virology,
immunology, physiology, embryology, and genetics.
One additional and important feature of the periodwas that from the late 1940s on, the new articu-
lation between experimental biology and clinical practice was rooted in a process of molecularization.
Molecules were increasingly considered by biomedical researchers as the most important analysis
units and intervention targets (Gaudillière, 2002; Quirke and Gaudillière, 2008). Escalating interest in
macromolecules such as viruses, and laterDNA,was typical of themolecularization of research objects.
Correlatively, the ﬁrst-order priority placed on the chemical designing of drugs and chemotherapy in
general was typical of the molecularization of medical targets. This has been powerfully illustrated
in domains, such as cancer, in which the mere idea of molecular intervention had been considered
extremely difﬁcult, not to mention impossible. This postwar molecularization impacted the study of
familial and hereditary diseases in ways that can be discussed from two angles: 1) that of the new
visibility acquired by inherited biochemical disorders; and 2) that of the transformation in uses of
pedigrees, their normalization along Mendelian lines, and their integration into the new practice of
genetic counseling.
Medical-genetics historians have shown how phenylketonuria (PKU) came to be an iconic disease
after World War II. This highly peculiar form of mental retardation was then traced back to a geneti-
cally determined defect of an enzyme, but it also became an “inborn error of metabolism,” a disease
J.-P. Gaudillière / ALTER, European Journal of Disability Research 5 (2011) 7–15 11
detected in newborns and treated through a drastic nutritional regime intended to reduce pheny-
lalanine intake in the diet (Kevles, 1985; Paul, 1995, 1998). Although the image of a curable and/or
preventable genetic disorder associated with PKU was grossly exaggerated, its visibility was highly
inﬂuential as it provided a vivid example of a fruitful connection between the genetic redeﬁnition of
the disease, its molecular diagnosis, and its (nutritional) treatment. PKU thus exempliﬁed a promising
alliance between biochemistry, genetics, and pediatrics, an alliance that would be able to prosper in
the biomedical landscape and foster a wave of inquiries on human Mendelian disorders.
Parallel to this story, the emergence of genetic counseling has often been linked to the institutional
reorganization of postwar genetics, and more particularly, to its entry into hospitals and medical-care
settings (Neel, 1994; Lindee, 2005). This very peculiar form of medical practice is however deeply
rooted in the molecularization of hereditary diseases. In 1946, the British geneticist Lionel Penrose
published a seminal article on PKU. The paper celebrated the biochemical and genetic reframing of the
disease, stressing the contrast betweennewknowledgeon thedisease and “old” eugenicsperspectives.
Penrose targeted the absurdity of any sterilization or elimination policy, arguing that PKU was not
a public-health issue. In parallel with the perspective of a nutritional handling of the disease, he
advocated another form of practice based on the knowledge of Mendelian transmission laws. “There
is however a wider eugenic aspect. Are we justiﬁed in allowing the further spread of a noxious gene
in the population? Here, I think, we must accept the inevitable, which is not, after all, very bad. It is
obviously unfair to discriminate between one carrier and another regarding which shall be allowed to
have offspring and which not, and we cannot reasonably sterilize 1% of the population. The practical
medical aim is to reduce the incidenceof PKU. This canbe accomplishedbypreventing consanguineous
matings in affected families, and ultimately by preventing all matings of two carriers” (Penrose, 1946).
Keeping PKU as an example, Penrose later argued in favor of a medical intervention that would
provide reproductive counseling to individuals with a familial history of the disease (Penrose, 1948,
1955). Carefully established pedigrees were central to this (hoped for) practice as they were neces-
sary for deﬁning the probability of transmission and helped to disclose painful medical information.
Although as a geneticist, Penrose played practically no role in the materialization of genetic counsel-
ing, the practice developedmore or less along the lines he had envisioned, at least regarding the role of
family trees. By the late 1960s, in the United Kingdom and in the United States, genetic counselingwas
ﬁrmly established as a medical procedure organizing the diagnosis and control of genetic disorders.
Its speciﬁcity was due to four features: 1) the idea that diagnosis was not necessarily the identiﬁcation
of an existing disease but the determination of a range of possibilities of various orders of importance
that could be deﬁned in quantitative terms with probabilities; 2) the use of family trees as a means to
collect and circulate information about both the diagnosis and the prognosis; 3) the fact that genetic
counseling was not a consultation focused on a single patient but on the medical handling of repro-
ductive units, i.e. a couple or even entire families; 4) in contrast with traditional clinical encounters,
emphasis was placed on the separation between the objective analysis of the situation and the choice
between existing options regarding reproductive life andmedical intervention (sterilization, abortion,
or possibly a therapeutic course).
Medical genetics in postwar France developed along similar lines. A good example of this con-
vergence is the work completed by the pediatricians’ group at the Children’s Hospital in Paris, which
played a leading role in the emergence of human genetics as a medical specialty. There, Maurice Lamy,
the ﬁrst professor of clinical genetics to be appointed in France, directed a service focusing on the iden-
tiﬁcation of “truly hereditary” diseases, meaning Mendelian genetic disorders. Differential diagnosis,
mode of transmission, and incidence were the main targets of investigations based on what can be
called Mendelian pedigrees. The latter showed three or four generations of affected or non-affected
individuals and provided the basis for aggregation, statistical calculus, and a probabilistic interpre-
tation of the transmission ratio. This is well illustrated by the local work on muscular dystrophy
(Gaudillière, 2002). Children affected with this peculiar form of paralysis were encountered in local
consultations for poliomyelitis. The ﬁnal analysis published by the group was based on 77pedigrees,
the comparison of which had made it possible to disentangle “myopathy” into two different diseases
deﬁned on the basis of their mode of transmission. Muscular dystrophy was accordingly mingling a
rare recessive autosomal disorder and a more frequent form of the disease linked to the X chromo-
some (de Grouchy, 1953; de Grouchy and Lamy, 1954). Pleading against the vagueness of all notions
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of hereditary transmission, not only did Lamy and his colleagues mobilize classical genetics concepts
to ﬁght the culture of transmission, they also adopted “inborn errors of metabolism” as a conceptual
means to associate, just as Penrose had, Mendelian pedigrees and biochemical testing.
The detailed story of genetic counseling in France remains to bewritten. In the context of this paper,
two features are worth underscoring. The ﬁrst is the important role played up to the late 1960s by
informal and local practices inpediatric services. The second is the scalingupphase,which tookplace in
the late 1960s with the institution of several medical-genetics services outside Paris. The countrywide
development of these services led, in the early 1970s, to the writing of the ﬁrst guidelines for this type
of medical activity. Again, the Paris Children’s Hospital is a good example of this institutionalization.
Genetic counseling did not exist as such in the 1950s, when hereditary-disorder cases were seen and
handled within different consultations. There were nonetheless some common features in the way
clinical cases were managed. Lamy, for instance, supplemented the diagnosis of Mendelian diseases
with advice to parents coming in the polio consultation, which provided the service with the large
majority of muscular-dystrophy patients included in the study on hereditary transmission.3 At the
same time, other members of the unit organized the diagnosis of PKU in newborns.
This local management of hereditary defects was the basis for the theorization and discussion of
public-health issues. In 1951, when he was appointed as the ﬁrst professor of clinical genetics, Lamy
ended his inaugural lecture with general considerations on the nature and role of what he called
“eugenic counseling.” “Once a pathology has been identiﬁed as hereditary or once a given pathologi-
cal pattern has been recognized as strongly inﬂuenced by hereditary factors, its mode of transmission
must be speciﬁed. It so happens that many diseases are inherited in a rather simple way. . . Read-
ing pedigrees and statistical analyses thus provides us with highly valuable and immediately useful
information. . . The genetics of the future will therefore favor prophylaxis. Rational prevention can
only be imagined if we learn how to identify from the mass the individuals affected with this hered-
itary fate. . . Once the carriers of noxious genes are identiﬁed, we shall know which marriages will
possibly result in unﬁt progeny and should in consequence be advised against” (Lamy, 1951). Twenty
years later, in the midst of the institutionalization phase, the meaning of what had become a major
practice within the unit had been radically altered. The “conseil génétique,” the same Lamy recom-
mended should be generalized, was no longer a public health or demographic issue, but a response to
the patients’ demands. “Progress in our knowledge of pathological heredity has or should have prac-
tical implications for prevention; I mean the need for organizing in France this genetic consultation,
which is already operational in foreign countries where the least objectionable services are offered. . .
Experience tells us that geneticists are asked for opinion and advice in four different situations. First
when somebody, male or female, is affected with an abnormality and fears he or she might pass it on.
More often, however, the request comes from a couple who has already experienced the birth of an
unwelcome child. Occasionally, the parents of a would-be couple asks for advice. Finally, counseling is
sought in relation to consanguinity issues” (Lamy, 1970). In all instances, in contrast to eugenic coun-
seling, genetic consultations were presented as providing objective statements and informed advice
while leaving the consulting couple or family to ponder the risks and make their own decisions.
We should not conclude from the example of Lamy and the Paris Children’s Hospital pediatricians
that all studies of pathological inheritance in postwar France were realigned along Mendelian and
biochemical lines. A signiﬁcant number of French physicians remained interested in terrain and con-
stitution, in various combinations of vertical and horizontal transmission of diseases, thusmaintaining
the idea of medical practice focusing on all the dimensions of the mother–infant relation, including
the nature of the reproductive cells, housing, and feeding. The above-mentioned Parisian pediatrician,
Raymond Turpin, was one of these physicians. An unexpected consequence of this positioning was
that he became increasingly reluctant to genetic counseling.
In the 1950s, Turpin gave up all references to eugenics but stressed the importance of progenesis as
an overall study of both constitutional and environmental factors that contribute to human reproduc-
tion, from the genesis of gametes to infant rearing. The Centre de progénèse he managed to establish at
the Paris Medical School was all at once a site for the (voluntary) teaching of medical and paramedical
3 J. Frézal, interview with the author.
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students, a (small) research facility, and a place where families with hereditary pathologies could seek
diagnosis and advice. Rather than genetic counseling, what was done there was medical consultation
operationalizing an overall approach to reproduction, from reproductive control to the “creation of
themost favorable environment for themoral, cognitive, and physical development of the individual.”
In the late 1940s and early 1950s, discussing his own version of “conseil progénésique,” Turpin recog-
nized the value of Mendelian transmission, pedigree analysis, and voluntary control of transmission,
but added that improving the environment in order to prevent the actual manifestation of disease
and facilitate the life of those affected with a hereditary predisposition remained the main task of the
physician. “While he should study the means to eradicate the obnoxious gene from the human genetic
pool, the physician must ﬁrst ﬁght morbid states that depend on hereditary as well as exogenous fac-
tors. Using appropriate prophylactic measures, improving general hygiene and nutrition, his role is to
redeem individuals from genetic inequality, for instance from their status of individuals predisposed
to tuberculosis” (Turpin, 1949, 1955).
Technological change and risk management: mass practice of prenatal diagnosis
The nature and status of genetic counseling changed rapidly in the 1970s to become a routine, not
to say mass practice. Sociological and historical studies have anchored this change in two series of
events (Koler and Burke, 1994; Rapp, 2000; Schwartz Cowan, 2008). The ﬁrst was the development of
chromosomal analysis as a diagnostic tool to supplement and eventually replace clinical examination
andbiochemical analysis.Historianshave taken the feministmovementof the1960sand the successful
mobilizations to abolish the legal ban on abortion inmany developed countries as the second andmost
important root of the reinvention of genetic counseling. The changes of the late 1960s and early 1970s
were, however, not restricted to thiswell-documented conjunction. They actually shifted themeaning
of genetic counseling,which ceased tobe aprocedure for controllingpathological heredity andevolved
into a practice for deﬁning and handling various risks related to the birth of sick and/or handicapped
children. The Down syndrome played a central role in this transformation. The French trajectory of
the disease sheds interesting light on the technical, medical, and social logics at work.
As mentioned above, before the war, the great majority of physicians emphasized the congenital
and environmental factors of “mongolism,” including the age of the mother. In Turpin’s new service
at the Trousseau pediatric hospital in Paris, studies of Down patients resumed in the 1950s under the
direction of a young physician, Jerôme Lejeune. Having failed the examination to become an intern,
Lejeune was hired as laboratory scientist. He renewed investigations on the morphological signs of
predispositions, focusing on palm-print abnormalities. In addition to his work on Down’s morphol-
ogy, Lejeunebecame interested in studies of radioactivity, chromosomes, andmutations, and imported
cytogenetics and karyotyping procedures into the service. By the late 1950s, the two lines of investiga-
tion converged in the statements that Down children presented an extra chromosome21, and that this
genetic feature could be used for diagnostic purposes. Neither the performing of karyotype analyses
nor this link between the identiﬁcation of a trisomy 21 and the clinical diagnosis of the disease proved
to be simple and straightforward to generalize (Hsu, 1979; Gaudillière, 2000b; Santesmases, 2011).
The most important conjunction for the advent of Down prenatal diagnosis was not, however, the
standardization of karyotyping but its association with amniocentesis. By the time Lejeune and his
colleague Marthe Gauthier stabilized the chromosomal origins of a well-known type of mental retar-
dation, the “amniotic tap” had entered the management of problematic pregnancies and hereditary
risks. Obstetricians started to use it to monitor the possible damages to fetuses to be born from moth-
ers “at risk” for rhesus incompatibility and to decide whether labor would have to be induced and if
a general transfusion would be necessary (Zimmermann, 1975). The ﬁrst combination of chromoso-
mal analysis and amniocentesis was achieved in 1959–1960. It was practiced, not to diagnose Down
syndrome, but to determine the sex of fetuses by using the ﬁbroblasts collected in the amniotic ﬂuid
and to evaluate a risk of hemophilia (Schwartz Cowan, 2008). Prenatal diagnosis of Down syndrome
was ﬁrst conducted in Denmark when new procedures for the laboratory culture of the collected cells
became available in the mid-1960s (Fuchs and Cederqvist, 1970).
In contrast to what is often assumed, abortion was not an external component of the emerging
procedure, i.e. something simply imposed on reluctant physicians by social movements. Before pre-
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natal diagnosis, medical abortion had a problematic but signiﬁcant role in the routine management of
pregnancies. This was certainly the case in Denmark, where the eugenics law granted the possibility
of abortion in the case of inherited risk of a non-curable abnormality for the fetus. It was also the case
in France, where the natalist commitments of the interwar period had left an opening for abortion,
i.e. when the life of the mother was at stake. In the 1950s, indications for a “therapeutic abortion”
were gradually extended to conditions bearing the certainty of major abnormalities in the newborn.
Cases of pregnantwomencontracting rubella provided theﬁrst publicly discussed condition, as rubella
dramatically increased the risk of deafness and blindness. However, it is very likely that from the late
1950s on, hospital services like those of the Paris Children’s Hospital informally performed therapeutic
abortion for other conditions, including hemophilia and muscular dystrophy.4
The result of technical innovation, newmedical practices, and changing perceptions of pregnancies
was not only that abortion could become amedical intervention—the difﬁcult but acceptable outcome
of a prenatal diagnosis—but also that this practicewas integrated into themulti-faceted procedures for
managing health with risk. Such management did not only rest on pedigrees, karyotyping techniques,
and probability computation within the individualized space of the genetic consultation. It soon came
to imply more overall forms of population management. The ﬁrst risk studies associated with the
emerging technical package were published in the mid-1970s in the United States and in the United
Kingdom. They were concerned with two issues: the risk of fetal loss as a consequence of amniocente-
sis and the costs of putative screening. The use of risk/beneﬁt calculations is more typical of this new
conﬁguration of public health than the cost/beneﬁt analysis that was occasionally mobilized to eval-
uate the proposals for systematically organized screening, which surfaced in the late 1970s in parallel
with the expansion of genetic counseling. For instance, a large clinical study on safety conducted by
the National Institute of Child Health and Human Development compared the rate of fetal loss and
the health of babies born from women having gone through prenatal diagnosis with those of babies
born from women not having done so. Its ﬁndings showed that there was no difference, a statement
which played a signiﬁcant role in the inclusion of the procedure in standard health packages in the
United States.5 Later studies provided a slightly different perspective, leading to the consensual rating
of 1% fetal losses due to the puncture. It is however characteristic of health-risk management that,
in the case of Down-syndrome screening protocols, this ﬁgure became part of another calculation
juxtaposing the 1% threshold with the age-related risk of bearing an affected child.6
Once stabilized, the prenatal diagnosis package seems to have beneﬁted from rapid generalization.
The two decades following the introduction of prenatal chromosomal analysis saw not only growth
in the number of examinations and the establishment of the screening scheme as part of reproduc-
tive medicine, but also an important diversiﬁcation of the diseases targeted and diagnosed, with or
without pregnancy termination. The latter dimension is often interpreted in terms of technical change
in human genetics, this time in relation to the development of DNA analysis and genome studies. It
can hardly be denied that DNA sequencing, the current manipulation of thousands of DNA markers,
and the identiﬁcation of a vast palette of mutations associated with monofactorial (and occasionally
plurifactorial) genetic disorders resulted inmore numerous and diverse prenatal diagnoses. It isworth
noting, however, that the main biotechnological drive was probably not molecular genetic analysis
but rather the changes in the capabilities and uses of prenatal imaging. In other words, the second
biomedicalization of pathological inheritance is less a question of molecules than is suggested by the
visibility of contemporary genomics. Unfortunately, apart froma few exceptions,what is known about
imaging techniques focuses on the early stages of innovation rather than on the routine management
of pregnancy, risk, and coming disabilities (Blum, 1992; Kevles, 1997; Levi, 1997; Mitchell, 2001). The
massive diffusion and the reﬁnements of ultrasound examination for prenatal care that have taken
place for the past 30 years remain to be properly investigated.
4 J. Boué, interview with the author.
5 See for instance: (NICHD, 1976).
6 On the complexity of this assemblage and its uses (Rapp, 2000).
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